Biktarvy, formally known as bictegravir, represents a powerful single-tablet therapy for managing HIV infection. This medication unites three essential antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It works by inhibiting the HIV's ability to copy within the body, considerably decreasing the viral quantity. For many